Simoni Leonard, Alimehmeti Ilir, Ceka Astrit, Tafaj Ermir A, Gina Mirald, Panariti Aldo, Xhafaj Fatjon, Dibra Alban, Goda Artan
Cardiovascular Disease, University Hospital Center "Mother Teresa", Tirana, ALB.
Health Commission, Academy of Sciences of Albania, Tirana, ALB.
Cureus. 2022 Jul 13;14(7):e26813. doi: 10.7759/cureus.26813. eCollection 2022 Jul.
Background Multiple studies conducted worldwide and in Albania documented an important reduction of acute ST-elevation myocardial infarction (STEMI) admissions during the Coronavirus Disease 19 (COVID-19) pandemic. There are few studies regarding STEMI admissions and outcomes during the ongoing pandemic after the initial lockdown. We aimed to study STEMI admissions and in-hospital outcomes after the COVID-19 lockdown period. Methods A retrospective single-center study was conducted, collecting data for all consecutive STEMI admissions from March 9th, (the first COVID-19 case) until April 30, the corresponding period of 2020 total lockdown, for years 2019 and 2021. The control period was considered the year 2019 [pre-pandemic (PP)] and the study period was in 2021 [ongoing pandemic (OP)]. The incidence rate ratio (IRR) 95% confidence interval (CI) was used to compare all-STEMI admissions, invasive procedures, and risk ratio (RR) 95% CI to compare the mortality and complications rate between the study and control period. Results The study included 217 STEMI patients admitted in 2019, and 234 patients during the 2021 period. The overall-STEMI admissions IRR is in a similar range during the 2021 OP compared to the 2019 PP period IRR=1.07 (95%CI 0.90-1.28). Similar invasive procedures were observed during OP compared to PP period, respectively for coronary-angiography IRR= 1.07; (0.87-1.31), for all-PCI [1.12 (0.92-1.35)], and primary percutaneous coronary interventions (PCI) [1.09 (0.89-1.34)]. The STEMI death rate during OP compared to PP period was similar (7.3 vs. 7.4%), RR=1.01 (0.53-1.96), and a non-significant lower primary-PCI-death rate (4.0 vs 4.8%), RR= 0.83 (0.30-2.3)]. Conclusions After the initial reduction of admissions and invasive procedures in STEMI patients during the 2020 lockdown period and the increase of all-STEMI mortality, the number of hospitalizations, invasive procedures, and mortality returned to a similar range during OP compared to the PP period despite a highly incident ongoing COVID-19 pandemic.
全球及阿尔巴尼亚开展的多项研究表明,在冠状病毒病19(COVID-19)大流行期间,急性ST段抬高型心肌梗死(STEMI)入院人数显著减少。关于初始封锁后正在进行的大流行期间STEMI入院情况及预后的研究较少。我们旨在研究COVID-19封锁期后STEMI的入院情况及院内预后。方法:进行一项回顾性单中心研究,收集2019年、2021年3月9日(首例COVID-19病例)至4月30日(2020年相应的全面封锁期)期间所有连续STEMI入院患者的数据。将2019年作为对照期[大流行前(PP)],2021年作为研究期[正在进行的大流行(OP)]。采用发病率比(IRR)95%置信区间(CI)比较所有STEMI入院情况、侵入性操作,采用风险比(RR)95%CI比较研究期与对照期之间的死亡率和并发症发生率。结果:该研究纳入了2019年入院的217例STEMI患者和2021年期间的234例患者。与2019年PP期相比,2021年OP期间总体STEMI入院IRR处于相似范围,IRR = 1.07(95%CI 0.90 - 1.28)。与PP期相比,OP期间观察到相似的侵入性操作,冠状动脉造影IRR = 1.07;(0.87 - 1.31),所有经皮冠状动脉介入治疗(PCI)[1.12(0.92 - 1.35)],以及直接经皮冠状动脉介入治疗(PCI)[1.09(0.89 - 1.34)]。与PP期相比,OP期间STEMI死亡率相似(7.3%对7.4%),RR = 1.01(0.53 - 1.96),直接PCI死亡率略低但无显著差异(4.0%对4.8%),RR = 0.83(0.30 - 2.3)。结论:在2020年封锁期STEMI患者入院人数和侵入性操作最初减少以及所有STEMI死亡率增加之后,尽管COVID-19大流行仍在高发,但与PP期相比,OP期间住院人数、侵入性操作和死亡率恢复到了相似范围。